Elevated Serum Levels of Vascular Endothelial Growth Factor Are Associated With Tumor-Associated Macrophages in Primary Breast Cancer
Authors:
- Luis ViciosoLVLuis Vicioso
- Francisco J. GonzalezFGFrancisco J. Gonzalez
- Martina AlvarezMAMartina Alvarez
- Nuria RibellesNRNuria Ribelles
- Manuel MolinaMMManuel Molina
- Antonia MarquezAMAntonia Marquez
- Lidia PerezLPLidia Perez
- Alfredo MatillaAMAlfredo Matilla
- Emilio AlbaEAEmilio Alba
- 1 January 2006
- journal article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 125 (1) , 111-118
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- The prognostic value of the AgNOR parameter in human breast cancer depends on the pRb and p53 statusJournal of Clinical Pathology, 2004
- Prognostic impact of VEGF, CD31, CD34, and CD105 expression and tumour vessel invasion after radical surgery for IB–IIA non-small cell lung cancerJournal of Clinical Pathology, 2004
- Expression profiles and functional implications of p53-like transcription factors in thymic epithelial cell subtypesInternational Immunology, 2004
- VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitmentJournal of Clinical Investigation, 2004
- Correlation between vascular endothelial growth factor, angiogenesis, and tumor-associated macrophages in invasive ductal breast carcinomaVirchows Archiv, 2001
- Angiogenesis: pathological, prognostic, and growth-factor pathways and their link to trial design and anticancer drugsThe Lancet Oncology, 2001
- A Proinflammatory Cytokine Inhibits P53 Tumor Suppressor ActivityJournal of Experimental Medicine, 1999
- Angiogenesis and metastasisEuropean Journal of Cancer, 1996
- Angiogenesis in cancer, vascular, rheumatoid and other diseaseNature Medicine, 1995
- The origin and function of tumor-associated macrophagesImmunology Today, 1992